|Articles|October 1, 2010
- BioPharm International-10-01-2010
- Volume 23
- Issue 10
BioPharm International, October 2010 Issue (PDF)
Biopharmaceutical Approvals in the US and EU: A Review
Advertisement
Articles in this issue
about 15 years ago
Uncertain Outlook for Biopharma Venture Capitalabout 15 years ago
Biopharmacetiucal Approval Trends in 2009about 15 years ago
A Quality Culture Can Be the Industry's Core Strengthabout 15 years ago
Biotech Companies Gain Support for Vaccine, Countermeasure Productionabout 15 years ago
Taking on the Challengesabout 15 years ago
Biotech Cools Off as Capital Markets Weakenabout 15 years ago
The Role of Noncritical Process Parameters in Quality by DesignNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
RNAnalytics CPHI Interview, Part Two: Nanoparticle Case Studies and Response to US mRNA Pullback
2
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
3
How Is AI Transforming Biomanufacturing and Biopharma Workforce Training?
4
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
5
